Tramadol Hydrochloride Articles
Labopharm's once-daily Ryzolt cleared by FDA
12 January 2009
Largest fake drug haul in Europe from India
13 October 2008
Biovail and Janssen sign tramadol supply and distribution accord
14 January 2008
Par and Ortho-McNeil resolve Ultracet patent dispute
30 July 2007
Labopharm hit by second FDA letter
11 June 2007
Biovail's 2005 revenue reaches $936M
3 April 2006
US FDA asks for more trials of Biovail's Tramadol
18 April 2005
FDA seeks more trials for Biovail's pain drug
11 April 2005
Biovail get approvable letter for tramadol
24 January 2005
Bioavail's Raliva ER gets approvable letter
8 November 2004
Biovail files NDA for Ralivia FlashDose
22 March 2004
Caraco expects $35M revenues in 2003
24 February 2003
Alpharma gets generic tramadol go-ahead in USA
1 July 2002
Labopharm losses deepen
29 April 2002
Caraco gets US OK for metformin/tramadol
4 February 2002
IVAX' paclitaxel gets ok to stay on US market
4 February 2002
J&J posts healthy increase in sales and earnings for 2001
28 January 2002
Labopharm sets up European subsidiary in Ireland.
21 January 2002
Grupo Vita begins Ph I VANH36 study
27 September 2001
Extended-release tramadol shows promise
7 September 2001
Johnson & Johnson net earnings rise 15.5%
19 April 2000
Healthy full-year results for many US pharmaceutical companies
27 January 2000
Roberts' propiram betters tramadol in Phase III
18 March 1999
USA's Most-Dispensed Rx Drugs In April 1998
20 May 1998
Strong Growth For US Drug Firms In 1997
28 January 1998
First Approval Of AHP's Duract
17 July 1997
Strong $ Impact On 1st Qtr At Johnson & Johnson
22 April 1997
Significant Increases For US Drug Firms In 1996
3 February 1997
Major US Drug Cos Post Strong Results In 3rd Qtr
28 October 1996
US Drug Majors See 2nd-Half Double-Digit Growth
29 July 1996
US Firms' Strong 1st Qtr Lifts Share Prices
29 April 1996
Tramadol Labeling Changes
15 April 1996
Transition For AHP in 1995; Year-End Results
5 February 1996
US FDA Approving Fewer NMEs, But Faster, In 1995
11 September 1995
Strong International Sales For US Cos In 2nd Qtr
31 July 1995
NSAID Debate Continues Apace In USA
13 March 1995
SEARLE LAUNCH IN UK
13 June 1994
Showing 1-41 of 41 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
